Sept 8: At the end of July, Citius Pharmaceuticals received a Complete Response Letter from the FDA pertaining to its Biologics License Application for Lymphir, an engineered IL-2-diphtheria toxin fusion protein intended to treat relapsed or refractory cutaneous T-cell lymphoma
The longitudinal clinical study included two groups: a healthy control group with no trauma exposure and a trauma-exposed group, the latter consisting of individuals with a current PTSD diagnosis ( N = 41) and those with subclinical PTSD symptoms but no formal diagnosis ( N = 24, with a mean CAPS total score of 12.7)
Our guides on foods to avoid on semaglutide and foods to avoid on tirzepatide help you identify trigger foods and build meals that support rather than sabotage your treatment
This makes Ozempic the only GLP-1 receptor agonist approved for this combined indication
When used along with healthy eating, regular exercise, and a dedication to long-term changes, they can make a positive difference in a person's life
